The AhR signaling pathway elevates the expression of β-catenin and of Wnt5a/b in the tumor tissue of patients with inflammatory breast cancer (IBC) that overexpresses AhR and its target gene/protein CYP1B1 [118]. Here, CYP1B1 is linked to inflammatory breast carcinoma.